These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs. Larrey D; Branch RA Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424 [No Abstract] [Full Text] [Related]
3. Drug pharmacokinetics in cardiac and hepatic disease. Williams RL; Benet LZ Annu Rev Pharmacol Toxicol; 1980; 20():389-413. PubMed ID: 6992701 [No Abstract] [Full Text] [Related]
4. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations]. Pellegrin P; Lesne M J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443 [TBL] [Abstract][Full Text] [Related]
5. [Dose adaptation of drugs for liver patients using a simple risk classification]. Zysset T; Bircher J Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941 [No Abstract] [Full Text] [Related]
6. Hepatic disease and drug pharmacokinetics. Williams RL; Mamelok RD Clin Pharmacokinet; 1980; 5(6):528-47. PubMed ID: 7002418 [TBL] [Abstract][Full Text] [Related]
7. Drug administration in hepatic disease. Williams RL N Engl J Med; 1983 Dec; 309(26):1616-22. PubMed ID: 6358891 [No Abstract] [Full Text] [Related]
8. Clearance and biologic half-life as indices of intrinsic hepatic metabolism. Perrier D; Gibaldi M J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599 [No Abstract] [Full Text] [Related]
11. Commentary: a physiological approach to hepatic drug clearance. Wilkinson GR; Shand DG Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821 [TBL] [Abstract][Full Text] [Related]
12. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. Pang KS; Rowland M J Pharmacokinet Biopharm; 1977 Dec; 5(6):625-53. PubMed ID: 599411 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics in the 1980s. Balant LP Clin Ther; 1984; 6(2):112-24. PubMed ID: 6705009 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics and administration of drugs in patients with hepatic failure]. Yamada S; Suou T Nihon Rinsho; 2007 Oct; 65 Suppl 8():53-7. PubMed ID: 18074517 [No Abstract] [Full Text] [Related]
15. Drug kinetics and hepatic blood flow. George CF Clin Pharmacokinet; 1979; 4(6):433-48. PubMed ID: 391463 [No Abstract] [Full Text] [Related]
16. Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation. Gilmore IT; Hofmann AF Gastroenterology; 1980 Jan; 78(1):177-9. PubMed ID: 7350025 [No Abstract] [Full Text] [Related]
17. An added complication in the estimation of apparent hepatic blood flow in vivo by pharmacokinetic parameters. Stella VJ; Yamaoka K; Levy RH Drug Metab Dispos; 1981; 9(2):172-3. PubMed ID: 6113120 [No Abstract] [Full Text] [Related]
18. Altered hepatic blood flow and drug disposition. Nies AS; Shand DG; Wilkinson GR Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954 [TBL] [Abstract][Full Text] [Related]
19. [Effects of liver disease on drug pharmacokinetics]. Su CY Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457 [No Abstract] [Full Text] [Related]
20. Drug disposition and liver disease. Wilkinson GR; Schenker S Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104 [No Abstract] [Full Text] [Related] [Next] [New Search]